Y mAbs Therapeutics
Price & Volume
Stats
See more52W Range | $3.55-$16.11 |
Market Cap | $195.2M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $88.6M |
Revenue Growth (YoY) | 4.9% |
Gross Profit (12 Mos) | $72.5M |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • 4 days ago
Y-mAbs Therapeutics announces results of annual shareholder meeting votes
Yahoo Finance • last month
Y-mAbs Therapeutics' SWOT analysis: oncology biotech stock faces growth hurdles
Yahoo Finance • 2 months ago
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
Yahoo Finance • 2 months ago
Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
About
CEO | Mr. Michael Rossi |
CFO | Mr. Peter P. Pfreundschuh CPA |
Address | 202 Carnegie Center, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 104 |
